[AIAC Guidelines on the management and treatment of atrial fibrillation. Update 2013. Associazione Italiana di Aritmologia e Cardiostimolazione]

G Ital Cardiol (Rome). 2013 Mar;14(3):215-40. doi: 10.1714/1234.13660.
[Article in Italian]
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Anti-Arrhythmia Agents / therapeutic use
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use
  • Atrial Fibrillation / complications
  • Atrial Fibrillation / drug therapy
  • Atrial Fibrillation / surgery
  • Atrial Fibrillation / therapy*
  • Calcium Channel Blockers / therapeutic use
  • Catheter Ablation
  • Disease Management
  • Drug Therapy, Combination
  • Electric Countershock
  • Fatty Acids, Omega-3 / therapeutic use
  • Heart Rate / drug effects
  • Hemorrhage / chemically induced
  • Hemorrhage / prevention & control
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Secondary Prevention
  • Septal Occluder Device
  • Stents
  • Thrombophilia / drug therapy
  • Thrombophilia / etiology

Substances

  • Adrenergic beta-Antagonists
  • Anti-Arrhythmia Agents
  • Anticoagulants
  • Calcium Channel Blockers
  • Fatty Acids, Omega-3
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors